Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 20, 2021 | Tavotek Biotherapeutics | $35.0M Series B | CS Capital | — |
| Jul 28, 2021 | Lupeng Pharmaceutical | $35.0M Pre-Series B | Temasek | Kaitai Capital, Bin Li, Lilly Asia Ventures, TF Capital |
| Dec 17, 2019 | Cellestia | $20.4M Series B | Fontus Capital, Partners Investment, PPF Group | — |